Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest ...
Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
Pharmaceutical giant Eli Lilly announced Wednesday that it plans to invest roughly $27 billion in United States manufacturing ...
A new wave of biotech venture capital firms, led by younger investors, is reshaping the industry with fresh strategies and a ...
It was FDA approved based on a clinical trial that showed it, overall, delayed the onset of insulin dependence from two years ...
The move comes after President Donald Trump warned Big Pharma leaders that he would impose tariffs on them if they refuse to ...
The news comes amid the possibility that President Trump imposes a 25% tariff on pharmaceuticals, which could encourage manufacturers to begin reshoring their services.
At the four new sites, Lilly expects to create more than 3,000 jobs for engineers, scientists, operations personnel, and lab technicians.
Eli Lilly and Company has announced plans to bolster its domestic medicine production across therapeutic areas by building ...
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
A new study has shown that two drugs - lecanemab and donanemab - could help patients stay independently by approximately 10–13 months in the early stage of Alzheimer's disease.